Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
-
2061
-
2062
-
2063
-
2064
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2065
-
2066
-
2067
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2068
-
2069
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2070
-
2071
-
2072
-
2073
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2074
-
2075
-
2076
-
2077
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2078
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2079
-
2080